1. Home
  2. Press release

Press Release

Lepu Biopharma: Puyouheng (pucotenlimab injection) obtains approval for marketing with a new indication, Breakthrough therapy designation granted by the CDE to MRG003 for the treatment of R/M NPC
Sep 29, 2022 15:40 JST
LEPU BIOPHARMA (2157.HK) announced that its first innovative biological drug, anti-PD-1 antibody - Puyouheng (generic name: pucotenlimab injection) has been approved for marketing by the National Medical Products Administration (NMPA) for the indication of unresectable or metastatic melanomas after the failure of previous systemic therapy.
More info..
Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX
Feb 23, 2022 18:11 JST
The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157.HK), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange") today
More info..
Lepu Biopharma Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange
Feb 10, 2022 09:50 JST
The biopharmaceutical company focusing on oncology therapeutics - Lepu Biopharma Co., Ltd. ("Lepu Biopharma" or the "Company", stock code: 2157), today announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited ("Hong Kong Stock Exchange").

More info..

Latest Release


Queensland's Stralis lands clean aviation breakthrough in Japan, announced at Expo 2025 Osaka
Aug 01, 2025 20:00 JST

Queensland leads global education charge at Expo 2025 Osaka
Aug 01, 2025 20:00 JST

Hitachi completes capital reorganization of air conditioning joint venture accelerating the deployment of green cooling solutions through "One Hitachi"
Aug 01, 2025 19:00 JST

Mitsubishi Motors and Security Bank launch Mitsubishi Motors Finance Philippines Inc.
Aug 01, 2025 17:00 JST

Honda Turkiye A.S. decided to establish Motorcycle Production Factory
Aug 01, 2025 16:45 JST

Honda Begins Joint Demonstration of Stationary Fuel Cell Power Station Designed to Utilize By-product Hydrogen and Repurposed Automotive Fuel Cells
Aug 01, 2025 11:20 JST

Isuzu's first battery-electric pickup "D-MAX EV" adopts eAxle
Aug 01, 2025 11:00 JST

Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030
Aug 01, 2025 10:20 JST

Revenue of LEQEMBI(R) (Preliminary Basis)
Jul 31, 2025 18:27 JST

Transfer of Sharp Mie Plant No.2 and part of the land at Mie Base
Jul 31, 2025 17:11 JST

TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
Jul 31, 2025 15:00 JST

DENSO Announces First Quarter Financial Results
Jul 31, 2025 11:25 JST

Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
Jul 31, 2025 11:20 JST

MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
Jul 31, 2025 11:00 JST

Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC

Jul 31, 2025 09:30 JST

New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease

Jul 31, 2025 09:20 JST

Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 31, 2025 09:10 JST

Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST

Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST

Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
 More Latest Release >>